Introduction
Cervical cancer is one of the foremost public health. It is evidently known that Papanicolaou (Pap) smear-based cytology population screening programmes significantly attenuates both the incidence of and mortality from cervical cancer particularly in high-income countries. A survey of National Cancer Institute (NCI), had been performed between 1973-1995 revealed 43% reduction of the incidence of and 46% reduction of mortality from cervical cancer. However, aforementioned cancer still have been remaining a substantial challenge in low-income countries due to the shortage of these kind of programs (Quinn et al., 1999; Singh et al., 2003; Parkin et al., 2005; Peto et al., 2005; Waggoner et al., 2010) .
World Health Organization (WHO) and The Turkish Ministery of Health propounded that a Pap test which would be performed for the women 35-40 years-old may
The statistical analyses
The statistical evaluation was performed with software SPSS for Windows, version 21.0 (SPSS IBM, New York, USA) utilizing descriptive statistical methods. As the descriptive statistical behaviour of the data, the values of the mean, standard deviation, ratio, and frequency were assigned. The distribution of the variables were controlled exerting Kolmogrov-Smirnov test (K-S test) . While Independent samples t-test had been using for the analyses of the qualitative data, χ 2 test had been using for the analyses of the quantitative data. The following results of the present study will be interpreted using p< 0.05 as the criterion for the statistical significance.
Results
A total of 32,578 women with the cervical cytology had been studied carefully utilizing the Pathology/ Cytology reports and the request papers including the hospital records., made out by the Gynecology and Obstetrics Clinics that we derived them from The Archive of Department of Pathology. The mean±SD of the participants in terms of the age was 42. 4±13.2 (range, 18-84) ; the parity in women with normal cytology was 2.8±1.9 (0-6 range) and in women with abnormal cytology was 1.6±1.5 (range 0-6); and being a regular smoker (consuming more than 5 cigarettes per day) was 9.6% in women with normal cytology and 9.7% in women with abnormal cytology. While 10,095 women (31%) were postmenopozal, 22,483 (69%) were reproductive. Just 424 women (1.3%) had a report for the cervical cytology of the smear during the last 5 years and 5,819 (17.9%) had been using the oral contraceptive.
There were 1 401 (4.3%) unsatisfactory smears and 1,093 (78%) of them were belonging to the ones coming from the external centers that had been appealed to us during the period of 9 years and 4 months. Overall, our prevalence of the cytological abnormality was 1.83% (598), with ASCUS in 1.18% (386), LSIL in 0.39% (127), HSIL in 0.16% (53), AGUS in 0.07% (23), squamous cell carcinoma in 0.02% (7), and adenoarcinoma in 0.006% (2). The number of the abnormal cervical cytology were 57 (9.5%) among the women aged between 30-34. (Table  1 ).
The distribution of the abnormal cervical cytology on the basis of the decades of cases were summarized in Table 2 . The mean age±SD (41.3±13.2) of women having the normal cytological findings were significantly lower than the mean age±SD (45.3±12.5) of women having the abnormal cervical cytology (p<0.05). 47.8% of the postmenopausal and 69.2% of the premenopausal women had the abnormal cytology with the statistical significance (p<0.05). While the mean±SD parity of the women having the abnormal cervical cytology was 1.6±1.5, normal cervical cytology was 2.8±1.9 with the statistical significance (p< 0.05). There was no significant DOI:http://dx.doi.org/10.7314/APJCP.2014 .15.5.2069 difference in smoking habit between the women with or without cytological abnormalities (Table 3) .
Bacterial vaginosis (5.6%) was detected as the most frequent infectious finding on the Pap smears of the present study followed by Candida albicans (2.7%), Actinomyces sp. (1.3%), Trichomonas vaginalis (0.2%) that they all were constituting approximately 9.8% of the participants.
The histopathological evaluation after the colposcopic biopsy of the women having the abnormal cytology of 95 ASCUS and 15 AGUS for all that the repeated Pap tests were 5 LSIL and 1 adenocarcinoma respectively. The colposcopic histopathology of the women having the cytology of 86 LSIL were 73 LSIL, 2 HSIL, and 11 normal cytology. The same results were 49 HSIL, 3 LSIL, and 1 squamous cell carcinoma for the ones having the cytology of 53 HSIL.
Discussion
The small DNA viruses infecting the epithelia of mucosa and skin, called human papillomaviruses (HPVs) are known as having more than 170 types including 13 high-risk and 7 probably high-risk HPVs. Although there is some substantial differences between the continents, HPV is currently considered the most common sexually transmitted virus worldwide even that may be as high as 80% with a lifetime prevalence. A German virologist, Harald zur Hausen, first demonstrated the relationship between the genital infections and cervical cancer in the early 1980s. Now, it is known that the low-risk HPV types trigger the benign lesions, but the high-risk ones have been established as the etiological agents of cervical cancer (Zur Hausen 1988; Baseman and Koutsky 2005; Li et al., 2011; Tachezy et al., 2013) . Specially, the five types of HPV were notified as the most prevalent regardless of the geographical distribution: HPV 16, 18, 52, 31, and 58 (Kahn, 2009; Bruni et al., 2010) .
Today, HPV is accepted as an causative agent of cervical cancer and its precursors. So, oncogenic and nononcogenic HPV viruses may lead to some viral cytopathic effect such as koilocytosis, with cellular enlargement, hyperchromasia, and irregularity of the nuclei which may be an alarming mark of cytological abnormality (Feichter et al., 2002; Castle et al., 2010; Zeferino et al., 2011) .
Pap test for cervical cancer secreening was introduced to practice in the United States in 1941 and led to the first systematic effort for cancer screening. After widely usage it has been associated with reduction in cervical cancer incidence and mortality. The Pap smear has become a model for cancer screening. However, the effectiveness of Pap smear screening for cervical cancer has never been demonstrated in a randomized trial. There are observational studies about effectivity of Pap test. In a study, cure rates were higher for women with cervical cancer detected by screening than for women whose cervical cancer was diagnosed by symptoms (difference in cure rates of 26 percent, 95%CI 16-36 percent) (Andrae et al., 2012) . Several studies demonstrated that cervical canser screening by Pap test reduces mortality rates. (Nygard et al., 2002; Abed et al., 2006; Aklimunnessa et al., 2006; Taylor et al., 2006) . Currently, there is no organized population-based screening program available for the whole World. Every country tries to evaluate their own screening programme. (Abdul Rashid et al., 2013; Demirtas, 2013) . There are two different techniques for cervical cytology: manual liquid based cytology and conventional Pap staining. Manual liquid based cytology can be considered as one of the suitable technique for screening with the above-mentioned benefits. It provides better morphology with increased detection of abnormalities and preservation of specimen for cell block and ancillary studies like immunocytochemistry and HPV detection. (Nandini et al., 2012; Moosa et al., 2014) .
Hitherto, different studies have exhibited the major and substantial variations considering the rates of ASCUS, LSIL, HSIL, AGUS, and cervical cancer (Forman 2003; Sanjose et al., 2003; Altaf 2006; Duggan et al., 2006; Turkish Cervical Cancer And Cervical Cytology Research Group, 2009; Castle et al., 2010; Kulig et al., 2010) . In the present study, 1.83% of the Pap smears had the abnormal cytology, with ASCUS in 1.18%, LSIL in 0.39, HSIL in 0.16%, AGUS in 0.07%, squamous cell carcinoma in 0.02%, and adenoarcinoma in 0.006%. Turkish Cervical Cancer and Cervical Cytology Group performed an important study with the participation of 33 healtcare centers consisting of 22 university and 11 government hospital clinics and private healthcare centers including 140 334 women for evaluation of the prevalence of cervical cytological abnormalities in Turkey. Their overall prevalence of cytological abnormality was 1.8% and prevalence of ASCUS, LSIL, HSIL, and atypical glandular cells (AGC) was 1.07%, 0.3, 0.17% and 0.08%, respectively. Our prevalence rates were very similar to those reported in the study of Turkish Cervical Cancer and Cervical Cytology Group (Turkish Cervical Cancer And Cervical Cytology Research Group 2009), an extended investigation in Turkey. But, the rates of the present study were much lower than the ones reported for Western populations, in general (de Sanjose et al., 2003; Duggan et al., 2006; Kroupis et al., 2007; Kulig et al., 2010; Marques et al., 2011) . However, our results were very similar to those reported from other Islamic countries like Saudi Arabia, Egypt, and Iran (Jamal et al., 2003; elAll et al., 2007; Nokiani et al., 2008) that may be ascribed to low prevalence of HPV (Tuncer et al., 2006; Ozalp et al., 2012) , religion, or the conservative cultures, akin to Turkish population. Besides, the mentioned rates detected by cervical screening may also vary with the nature of populations screened. For instance, the rates were reported as higher than the control groups at a clinic for sexually transmitted disease and among prostitutes/sex workers (Shlay et al., 1998; Nunez et al., 2002; Mak et al., 2004; International Collaboration of Epidemiological Studies of Cervical Cancer, 2007) posing the importance of early detection of cervical cytological abnormalities especially in the populations at high risk.
In the present study, we computed the rates of unsatisfactory smears as 4.3%. However, 78% of whole unsatisfactory smears were accounting for the ones coming from the external centers. So, it may also revealed the importance of the education and the training of midwives and nurses in Early Cancer Screening, Diagnosing and Education Centers. The ASCUS/SIL ratio has been used for evaluating the quality measurement tool in terms of intra-and inter-laboratory comparision. In USA, 1166 cytology laboratories had been analysed by a nationwide survey and 80% of them reported a ASCUS/SIL ratio between the range of 0.64 and 4.23. Finally, the median ratio was calculated as 2.0 in this survey (Davey et al., 2000; . Our ASCUS/SIL ratio was 2.14, similar to the reported in USA, that may point out the quality of our laboratory may be comparable with the mentioned ones.
Smoking is conceded as a risk factor for squamous cancer and squamous intraepithelial lesions (International Collaboration of Epidemiological Studies of Cervical Cancer 2007). Contrarily, there was no significant difference in the rates of cervical cytological abnormalities between smokers and nonsmokers in the present study.
As is customary, the microorganisms, detected on the Pap smear were diagnosed in the present study. According to our results, the most frequent one was bacterial vaginosis (5.6%), followed by Candida albicans (2.7%), Actinomyces sp. (1.3%), Trichomonas vaginalis (0.2%). As a whole, the infectious findings on the Pap smeaers were constituting approximately 9.8% of the participants. Because of the production of microfloral carcinogenic nitrosamines, bacterial vaginosis has been insinuated in the progression of cervical displasia, as well as HPV (Pavic, 1984; Gillet et al., 2012; Jahic et al., 2013) .
It is a remarkable point that the rate of abnormal cervical cytology of the women aged between 30 and 34 were constituting 9.5% of the whole abnormal cytologies among the population screened. The Turkish Ministry of Health, The Cancer Control Department declared "The National Standarts for the Screening of Cervical Cancer" in 2007 in which cytology alone every 5 years was recommended for the women aged 35-65 (Tuncer 2007) . Afterwards, The Cancer Control Department declared "The New National Standarts for the Screening of Cervical Cancer" in December 2012 in which HPV test or cytology every 5 years was recommended for the women aged 30-65 (The National Standarts for the Screening of Cervical Cancer in 2012a; 2012b). It means for the present study that our rate of abnormal cytology of the women aged between 30-34, constituting 9.5% of the whole abnormal result, would be excluded according to previous standarts for the screening of cervical cancer. Besides, Saslow et al. (2012) offered no screening before aged 21; cytology alone every 3 year for aged between 21-29; HPV and cytology "cotesting" every 5 year (preferred), cytology alone every 3 year (acceptable) for aged between 30-65; no screening following adequate negative prior screening after aged 65 as a summary of recommendations of American Cancer Society (ACS); American Society for Colposcopy and Cervical Pathology (ASCCP), and American Society for Clinical Pathology (ASCP) screening guidelines for the prevention and early detection of cervical cancer.
So, our results were encouraging the national and international guidelines those accept the age of 30 as the starting point for the mentioned screenings.
Our limitations were not inquiring about the number of pregnancies and sexual partners, age at marriage, and not performing HPV testing those would have been utilized for the risk stratification from which some data about the mentioned risk factors may have been derived.
Conclusively, the incidence, mortality, and morbidity of cervical cancer have been reduced by means of early detection of the cervical abnormalities particularly in the high-income countries having the regular cervical cancer screening programmes. Cervical cancer screening remains an evolving field with new HPV DNA tests, and development of new technologies. However, Pap smeaer tests are cheap, easy to perform, and have been embraced as the effective population screening method extensively. In spite of our limitations and the limited number of the cases, the present study supply the data for the period of approximately a decade. Our rates of the cytological abnormalities were much lower than the ones in Western populations in general but very similar to those reported from other Islamic countries. Besides, it is pointed out in this study that the rate of abnormal cervical cytology of the women aged 30-34 could not been underestimated, so our results were supporting the screening guidelines starting from the age of 30. The further multicentered prospective high volumed studies including HPV vaccination and comparing the starting points in terms of age are required.
